Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung…
この記事を読む
記事一覧 32ページ
この記事を読む
PD-L1低発現例での初回治療としてのペムブロリズマブ単剤をどう考えるか
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-c…
この記事を読む
PS2に対する免疫療法
Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evid…
この記事を読む
Uncommon mutationの治療開始は第1世代TKIか殺細胞性抗がん剤か
Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st g…
この記事を読む
オシメルチニブはオリゴPDが多い？
Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study. Schmid S et al. Lung Cancer. …
この記事を読む
臨床研究と観察研究、一致しないのは偶然だけ
Comparison of Population-Based Observational Studies With Randomized Trials in Oncology. Soni PD et al. J Clin Oncol. 20…
この記事を読む
TMBとDNA修復変異との関係
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Ce…
この記事を読む
PACIFIC試験：欧州でのデュルバルマブの使用制限への反論
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non…
この記事を読む
ICI治療、腺癌での肺臓炎発症は高リスク？
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. Sure…
この記事を読む
診断後の禁煙の有用性
Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small ce…